Camphor Attenuates Hyperalgesia in Neuropathic Pain Models in Mice
DOI: https://doi.org/10.2147/JPR.S398607
IF: 2.8319
2023-03-11
Journal of Pain Research
Abstract:Ziyuan Li, 1, &ast Yu Gan, 1, &ast Ting Kang, 1, &ast Yi Zhao, 1 Tianguang Huang, 2 Yuhao Chen, 3 Jin Liu, 1 Bowen Ke 1 1 Department of Anesthesiology, Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China; 2 Frontiers Science Center for Disease-Related Molecular Network, Sichuan University West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China; 3 West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Bowen Ke, Department of Anesthesiology, Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Wuhou District, Chengdu, Sichuan, People's Republic of China, Tel +86-28-85422114, Fax +86-28-85582944, Email Background: The treatment of neuropathic pain is still a major troublesome clinical problem. The existing therapeutic drugs have limited analgesic effect and obvious adverse reactions, which presents opportunities and challenges for the development of new analgesic drugs. Camphor, a kind of monoterpene, has been shown anti-inflammatory and analgesic effects in traditional Chinese medicine. But we know little about its effect in neuropathic pain. In this article, We have verified the reliable analgesic effect of camphor in the neuropathic pain model caused by different predispositions. Methods: The nociceptive response of mice was induced by transient receptor potential A1 (TRPA1) agonist to verify the effect of camphor on the nociceptive response. Multiple paclitaxel (PTX) injection models, Single oxaliplatin (OXA) injection models, Chronic constriction injury (CCI) models and Streptozotocin-induced (STZ) diabetic neuropathic pain models were used in this study. We verified the analgesic effect of camphor in mice by acetone test and conditioned place aversion test. At the same time, comparing the adverse reaction of nervous system between camphor and pregabalin at equivalent dose in locomotor activity test and rotarod test. Using patch clamp to verify the effect of camphor on dorsal root ganglion (DRG) excitability. Results: In behavioral test, compared with vehicle group, camphor significantly reduced the spontaneous nociception caused by TRPA1 agonist-formalina and allyl isothiocyanate (AITC). Compared with vehicle group, camphor significantly reduced the flinching and licking time in neuropathic pain model mice, including PTX, OXA, STZ and CCI induced peripheral neuralgia models. Compared with vehicle group, pregabalin significantly increased the resting time and reduced the average speed without resting and distance in locomotor activity test, reduced the time stayed on rotarod in rotarod test. In patch clamp test, compared with vehicle group, camphor significantly reduced the action potential (AP) firing frequency of DRG. Conclusion: Camphor can alleviate the symptoms of hyperalgesia in various neuropathic pain models, and has no obvious adverse reactions compared with pregabalin. This effect is related to the down-regulation of DRG neuron excitability. Keywords: camphor, neuropathic pain, TRPA1, hyperalgesia According to statistics in USA, the annual total cost of pain has exceeded cardiovascular disease, cancer and diabetes, up to $600 million. 1 With the acceleration of global aging, neuropathic pain has become a chronic pain disease affecting 7–10% of the global population. 2 The burden of neuropathic pain will be further aggravated. Neuropathic pain has complex symptoms and poor prognosis. In addition, the effect of analgesic drugs on the market is not ideal, which greatly reduces the quality of life of patients. In view of the current market gap of analgesic drugs for neuropathic pain, screening molecules with analgesic activity from natural products has become a feasible idea to solve neuropathic pain. China has rich medicinal plant resources, and a large part of medicinal plants are monoterpenes. Monoterpenes which have been used for medical purposes for centuries are important raw material in medicine, food and cosmetics industry and often used as aromatics, preservatives, flavoring agents and disinfectants. 3 A ton of monoterpenoids, for instance, menthol and 1.8-cineole have been utilized for anesthetic, analgesic, anti-inflammatory. 4,5 Camph -Abstract Truncated-
clinical neurology